MIRA Pharmaceuticals logo
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.6581
-0.0240 (-3.52%)
At close: Oct 15, 2026, 4:00 PM EDT
0.6501
-0.0080 (-1.22%)
After-hours: Oct 15, 2026, 7:43 PM EDT

MIRA Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-9.4-10.49-8.02-8.53-7.05-2.15
Net Income
-31.04-32-7.85-11.98-7.06-2.18
Earnings Per Share
-0.86-1.35-0.51-0.86-0.40-0.17
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.1111.032.834.60.352.81
Total Debt
-0.57-0.010.490.29
Net Cash (Debt)
8.1110.462.834.6-0.142.52
Net Cash Growth
1010.70%269.13%-38.38%---
Net Cash Per Share
0.230.440.180.33-0.010.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.64-4.66-5.56-4.53-5.6-1.38
Free Cash Flow
-4.64-4.66-5.56-4.53-5.6-1.38
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.